BIOTIME INC

Profile

Company Names

BIOTIME INC

Addresses

1301 HARBOR BAY PARKWAY, ALAMEDA, CA 94502

1301 HARBOR BAY PARKWAY, SUITE 100, ALAMEDA, CA 94502

Phone Numbers

5105213390

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

CA

Total Amount Raised:

$28,960,502.00

Number of Funding Rounds:

7
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
7
2014-03-04 
$3,500,000.00 
$15,000,000.00 
$11,500,000.00 
Equity 
6
2011-03-21 
$3,600,000.00 
$3,600,000.00 
$0.00 
Equity 
5
2011-01-28 
$2,300,000.00 
$2,300,000.00 
$0.00 
Equity 
4
2010-05-07 
$8,000,000.00 
$8,000,000.00 
$0.00 
Equity 
3
2010-04-27 
$61,220.00 
$61,220.00 
$0.00 
Equity 
2
2009-05-13 
$8,000,000.00 
$16,800,000.00 
$8,800,000.00 
Equity 
1
2009-04-15 
$3,499,282.00 
INDEFINITE 
INDEFINITE 
Equity, Debt 
People
First Name
Middle Name
Last Name
Titles
Related Companies
FRANKLIN 
M. 
BERGER 
DIRECTOR
SEATTLE GENETICS INC /WA   |  BIOTIME INC   |  TOCAGEN INC   |  WALKING FISH THERAPEUTICS, INC.
NEAL 
C 
BRADSHER 
DIRECTOR
BIOTIME INC
ARNOLD 
I 
BURNS 
DIRECTOR
BIOTIME INC
ROBERT 
N 
BUTLER 
DIRECTOR
BIOTIME INC
ABRAHAM 
E 
COHEN 
DIRECTOR
BIOTIME INC
STEPHEN 
C. 
FARRELL 
DIRECTOR
BIOTIME INC
WALTER 
 
FUNK 
EXECUTIVE OFFICER
BIOTIME INC
VALETA 
 
GREGG 
DIRECTOR
BIOTIME INC
VALETA 
A 
GREGG 
DIRECTOR
BIOTIME INC
ALFRED 
D 
KINGSLEY 
DIRECTOR
BIOTIME INC   |  RECYTE THERAPEUTICS, INC.   |  ASTERIAS BIOTHERAPEUTICS, INC.   |  ONCOCYTE CORP
PEDRO 
 
LICHTINGER 
DIRECTOR
VELCERA, INC.   |  BIOTIME INC   |  ASTERIAS BIOTHERAPEUTICS, INC.   |  GEMPHIRE THERAPEUTICS INC.   |  CHEMIOCARE INC.   |  STARTON THERAPEUTICS INC.
HENRY 
L. 
NORDHOFF 
DIRECTOR
PLC DIAGNOSTICS INC   |  BIOTIME INC
ROBERT 
W 
PEABODY 
EXECUTIVE OFFICER
BIOTIME INC   |  ASTERIAS BIOTHERAPEUTICS, INC.
JUDITH 
 
SEGALL 
EXECUTIVE OFFICER, DIRECTOR
BIOTIME INC   |  RECYTE THERAPEUTICS, INC.   |  ASTERIAS BIOTHERAPEUTICS, INC.   |  PHYTHERA THERAPEUTICS INC.
STEVEN 
A 
SEINBERG 
EXECUTIVE OFFICER
BIOTIME INC
HAL 
 
STERNBERG 
EXECUTIVE OFFICER, DIRECTOR
BIOTIME INC
WILLIAM 
P. 
TEW 
EXECUTIVE OFFICER
BRASSICA PROTECTION PRODUCTS LLC   |  BIOTIME INC
GREGG 
 
VALETA 
DIRECTOR
BIOTIME INC
ANDREW 
C. 
VON ESCHENBACH 
DIRECTOR
BIOTIME INC   |  CELULARITY INC
HAROLD 
 
WAITZ 
EXECUTIVE OFFICER, DIRECTOR
BIOTIME INC
MICHAEL 
D 
WEST 
EXECUTIVE OFFICER, DIRECTOR
BIOTIME INC   |  RECYTE THERAPEUTICS, INC.   |  ASTERIAS BIOTHERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2014-03-07
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
$1,000,001 - $5,000,000 
Equity 
2014-03-04 
2011-03-24
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
$1,000,001 - $5,000,000 
Equity 
2011-03-21 
2011-02-02
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
$1,000,001 - $5,000,000 
Equity 
2011-01-28 
2010-05-21
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
$1,000,001 - $5,000,000 
Equity 
2010-05-07 
2010-05-05
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
$1,000,001 - $5,000,000 
Equity 
2010-04-27 
2009-07-14
D/A
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
$1,000,001 - $5,000,000 
Equity 
2009-05-13 
2009-05-21
D/A
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
$1,000,001 - $5,000,000 
Equity, Debt 
2009-04-15 
2009-05-18
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
$1,000,001 - $5,000,000 
Equity 
2009-05-13 
2009-04-28
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
$1,000,001 - $5,000,000 
Equity, Debt 
2009-04-15 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
EQUITY SOURCE PARTNERS
140227
UNKNOWN
NONE
NONE
NONE
ROBERT KINGSLEY
NONE